Nachrichten zur MacroGenics Aktie

MacroGenics to Present at the J.P. Morgan Healthcare Conference

Rockville, MD, Jan. 13, 2020 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused…

MacroGenics Outlines Corporate Priorities for 2020

Rockville, MD, Jan. 09, 2020 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused…

MacroGenics files to offer up to $50M in shares

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics files $250M shelf offering

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics files U.S. application for margetuximab for HER2+ breast cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics Announces Submission of Margetuximab Biologics License Application to U.S. FDA

ROCKVILLE, MD, Dec. 19, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on…

Macrogenics reiterated as outperform at Leerink

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics (MGNX) Investor Presentation - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics down 3% on uncertainty of margetuximab survival benefit

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics Presents Results from the SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer at the San Antonio Breast Cancer Symposium

Biologics License Application (BLA) submission to FDA expected before the end of 2019 Biologics License Application (BLA) submission to FDA…

MacroGenics Presents Flotetuzumab Data in Patients with Primary Induction Failure and Early Relapsed Acute Myeloid Leukemia at the 2019 ASH Annual Meeting

Conference call scheduled for today at 8:00 p.m. ET Conference call scheduled for today at 8:00 p.m. ET...…

MacroGenics to Participate in the Evercore ISI HealthCONx Conference

Rockville, MD, Dec. 02, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused…

MacroGenics -6.1% premarket as Morgan Stanley turns bear

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

DEADLINE ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: November 12, 2019

NEW YORK , Nov. 12, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz &…

MacroGenics, Inc. (MGNX) CEO Scott Koenig on Q3 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics (MGNX) Investor Presentation - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Macrogenics Inc (MGNX) Q3 2019 Earnings Call Transcript

MGNX earnings call for the period ending September 30, 2019....…

MacroGenics (MGNX) Reports Q3 Loss, Lags Revenue Estimates

MacroGenics (MGNX) delivered earnings and revenue surprises of 4.21% and -19.66%, respectively, for the quarter ended September 2019. Do the…

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against MacroGenics, Inc. and Encourages Investors to Contact the Firm

NEW YORK , Nov. 6, 2019 /PRNewswire/ -- Bragar Eagel & Squire, P.C., a…

MacroGenics announces initiation of phase 2/3 MAHOGANY study of margetuximab in gastric or gastroesophageal junction cancer

"The MAHOGANY study for patients with gastric or gastroesophageal junction cancer is designed to support registration of margetuximab and is…

MacroGenics launches mid-stage Mahogany study in gastric or gastroesophageal junction cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why MacroGenics Is Tanking Today

Shares sink after the company provides investors with a clinical update. Here are the must-know details....…

Macrogenics down 14% premarket on doubts with margetuximab data

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

The Daily Biotech Pulse: Eli Lily Revenues Trail Estimates, Moderna Gets Fast Track Designation, MacroGenics Lukewarm Breast Cancer Data

Heres a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week…

Macrogenics margetuximab shows survival benefit in late-stage breast cancer study

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Lifshitz & Miller LLP Announces Investigation of Church & Dwight Co., Fibrocell Science, Inc., MacroGenics, Inc., MINDBODY, Inc., PaySign, Inc., Zebra Technologies Corporation and Zynerbia Pharmaceuticals

NEW YORK , Oct. 8, 2019 /PRNewswire/ --...…

ROSEN, A LEADING LAW FIRM, Reminds MacroGenics, Inc. Investors of Important Deadline in Securities Class Action - MGNX

NEW YORK , Oct. 5, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor…

MacroGenics (MGNX) Investor Presentation - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics: Decent Data, Strong Cash, Upcoming Catalysts, One Risk. Subscribe to Seeking Alpha for more:

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MGNX NOTICE: ROSEN, A LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against MacroGenics, Inc.

NEW YORK , Sept. 19, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights…

Hagens Berman Notifies Investors That Lost Money in MacroGenics (MGNX)

SAN FRANCISCO , Sept. 18, 2019 /PRNewswire/ -- Hagens Berman notifies MGNX investors of a…

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In MacroGenics, Inc. To Contact The Firm

NEW YORK , Sept. 18, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national…

MGNX CLASS ACTION ALERT: Bernstein Liebhard LLP Announces the Filing of a Securities Class Action Lawsuit Against MacroGenics, Inc.

NEW YORK , Sept. 17, 2019 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor…